Skip to main content
$0.91 -$0.02 (-2.5%)

04:00 PM EST on 12/03/21

VYNE Therapeutics Inc. (NASDAQ:VYNE)

CAPS Rating: 1 out of 5

Current Price $0.91 Mkt Cap $48.7M
Open $0.93 P/E Ratio 0.00
Prev. Close $0.91 Div. (Yield) $0.00 (0.0%)
Daily Range $0.90 - $0.94 Volume 490,990
52-Wk Range $0.90 - $13.20 Avg. Daily Vol. 715,386

Caps

How do you think NASDAQ:VYNE will perform against the market?

Add Stock to CAPS Watchlist

All Players

8 Outperform
6 Underperform
 

All-Star Players

0 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:VYNE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

marekz (53.79)
Submitted April 26, 2020

stock was brutally beaten down for missing an FDA approval on it's last medicine, but that disregards two very promising drugs for skin conditions, including a break-through acne medicine that broke initial prescription records before the coronavirus… More

SmartAce (99.68)
Submitted August 08, 2019

You don't realize how old a movie is until you see the computer in it.

NASDAQ:VYNE VS S&P 500 (SPY)

NASDAQ:VYNE Summary

Fools bullish on NASDAQ:VYNE are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about VYNE.

Recs

0
Member Avatar NeilSaskatchewan (< 20) Submitted: 7/10/2020 1:30:03 PM : Outperform Start Price: $27.00 NASDAQ:VYNE Score: -139.09

Amzeeq has blockbuster potential. It is the first and only medication to offer the proven efficacy of minocycline via a topical solution, thus minimizing systemic absorption and its consequent side effects. This could truly change the landscape of acne treatment, and offer a real benefit to the over 600 million people who suffer from it.

Leaderboard

Find the members with the highest scoring picks in VYNE.

Score Leader

whatsthepoint

whatsthepoint (99.96) Score: +195.81

The Score Leader is the player with the highest score across all their picks in VYNE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Toprope101 99.62 3/10/2020 Underperform 5Y $57.28 -98.39% +62.01% +160.41 0 Comment
WSMOOT19 74.50 7/8/2020 Underperform 1Y $28.00 -96.71% +43.09% +139.80 0 Comment
RANEsq 28.62 8/17/2020 Underperform 5Y $25.92 -96.45% +33.17% +129.62 0 Comment
whatsthepoint 99.96 2/16/2021 Underperform 5Y $9.96 -90.76% +14.61% +105.37 0 Comment
wallet2061 68.08 5/7/2021 Underperform 5Y $3.64 -74.73% +7.19% +81.91 0 Comment
SnPee500 69.98 8/19/2021 Underperform 5Y $1.52 -39.47% +3.16% +42.63 0 Comment
13Bravo 65.80 8/26/2021 Outperform 5Y $1.57 -41.49% +0.63% -42.11 0 Comment
Jatin 47.19 7/8/2021 Outperform 5Y $3.00 -69.33% +4.96% -74.30 0 Comment
tilolo76 55.16 7/6/2021 Outperform 5Y $3.18 -71.07% +4.20% -75.27 0 Comment
slnoutperform < 20 7/6/2021 Outperform 5Y $3.26 -71.78% +3.75% -75.53 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for VYNE.